The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope (Q36060423)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

phase III clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

13

object named as

Nelson L Michael

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Jeffrey R Currier

17

object named as

Jeffrey R Currier

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

18

object named as

Jerome H Kim

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Supachai Rerks-Ngarm

14

object named as

Supachai Rerks-Ngarm

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Mary A Marovich

16

object named as

Mary Marovich

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

8

object named as

Doris Thelian

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Sorachai Nitayaphan

9

object named as

Sorachai Nitayaphan

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Punnee Pitisuttithum

10

object named as

Punnee Pitisuttithum

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Somsak Chantakulkij

5

object named as

Somsak Chantakulkij

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Alexandra Schuetz

4

object named as

Alexandra Schuetz

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Jaranit Kaewkungwal

12

object named as

Jaranit Kaewkungwal

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Silvia Ratto-Kim

2

object named as

Silvia Ratto-Kim

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Weerawan Chuenarom

3

object named as

Weerawan Chuenarom

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Mark S de Souza

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Bessara Nuntapinit

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Anais Valencia-Micolta

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Robert M Paris

11

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Bonnie Mathieson

15

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Ministry of Public Health–Thai AIDS Vaccine Evaluation Group Collaborators

19

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

23 April 2012

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Journal of Immunology

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

188

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

5166-5176

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

The Genotype of Early-Transmitting HIV gp120s Promotes α4β7 –Reactivity, Revealing α4β7 /CD4 T cells As Key Targets in Mucosal Transmission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Cytolytic CD4 T cells in viral immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Immune Responses to HIV Vaccines and Potential Impact on Control of Acute HIV‐1 Infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4 T cell-B cell collaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Preserved central memory and activated effector memory CD4 T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Progress and obstacles in the development of an AIDS vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Functional signatures of protective antiviral T-cell immunity in human virus infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Virus-specific CD4 T cells: ready for direct attack

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4( ) T cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8 T cells: correlation with viral load

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Similarities and differences in CD4 and CD8 effector and memory T cell generation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

CD4( ) T helper cells and the role they play in viral control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

HIV preferentially infects HIV-specific CD4 T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Establishment and characterization of human immunodeficiency virus type 1 (HIV-1) envelope-specific CD4 T lymphocyte lines from HIV-1-seropositive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

2 October 2017

Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

11 July 2018

IL-2 producing memory CD4 T lymphocytes are closely associated with the generation of IgG-secreting plasma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

23 September 2018

Flow-cytometric detection of vaccinia-induced memory effector CD4( ), CD8( ), and gamma delta TCR( ) T cells capable of antigen-specific expansion and effector functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

23 September 2018

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

23 September 2018

Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

23 September 2018

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

23 September 2018

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8 cytotoxic T lymphocyte responses in seronegative volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

23 September 2018

Cytotoxic-T-Cell Responses, Viral Load, and Disease Progression in Early Human Immunodeficiency Virus Type 1 Infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

23 September 2018

Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in human immunodeficiency virus-infected persons.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383859

23 September 2018

Identification of circulating antigen-specific CD4 T lymphocytes with a CCR5 , cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22529301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of CD4 human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22529301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/22529301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV/AIDS preventive vaccine 'prime-boost' phase III trial: foundations and initial lessons learned from Thailand

1 reference

https://pubmed.ncbi.nlm.nih.gov/22529301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic granule release dominates gag-specific CD4 T-cell response in different phases of HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22529301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a novel HIV type 1 CRF01_AE cytotoxic T lymphocyte (CTL) epitope restricted by an HLA-Cw0602 allele and a novel HLA-A0206/peptide restriction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22529301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/22529301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of CD4( ) CTLs ex vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/22529301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison Between Env-Specific T-Cell Epitopic Responses in HIV-1-Uninfected Adults Immunized with Combination of ALVAC-HIV(vCP205) Plus or Minus rgp160MN/LAI-2 and HIV-1-Infected Adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/22529301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4049/JIMMUNOL.1102756

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36060423&oldid=1978645873"